Encapsulating peritoneal sclerosis: the state of affairs
Authors:
- Mario R. KorteMKMario R. Korte
- Denise E. SampimonDSDenise E. Sampimon
- 2 August 2011
- journal article
- review article
- Published by Springer Nature in Nature Reviews Nephrology
- Vol. 7 (9) , 528-538
Abstract
Encapsulating peritoneal sclerosis (EPS) is a severe complication of long-term peritoneal dialysis (PD) with a 50% mortality rate. EPS is characterized by progressive and excessive fibrotic thickening of the peritoneum, leading to encapsulation of the bowels and intestinal obstruction. At present, EPS cannot be detected with certainty during its early stages; however, a progressive loss of ultrafiltration capacity often precedes its development. Studies that attempted to elucidate the pathogenesis of EPS have shown that the duration of exposure to PD fluids is the most important risk factor for EPS, and that young age and possibly the effects of peritonitis are additional contributory factors. The pathophysiology of EPS is probably best described as a multiple-hit process with a central role for transforming growth factor β. A form of EPS that develops shortly after kidney transplantation has also been recognized as a distinct clinical entity, and may be a common form of EPS in countries with a high transplantation rate. Criteria have been developed to identify EPS by abdominal CT scan at the symptomatic stage, but further clinical research is needed to identify early EPS in asymptomatic patients, to clarify additional risk factors for EPS and to define optimal treatment strategies.Keywords
This publication has 172 references indexed in Scilit:
- Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS StudyNephrology Dialysis Transplantation, 2010
- The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosisNephrology Dialysis Transplantation, 2010
- Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cellsMatrix Biology, 2010
- High glucose decreases collagenase expression and increases TIMP expression in cultured human peritoneal mesothelial cellsNephrology Dialysis Transplantation, 2007
- Lens-Specific Expression of TGF-β Induces Anterior Subcapsular Cataract Formation in the Absence of Smad3Investigative Ophthalmology & Visual Science, 2006
- Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatmentClinical and Experimental Nephrology, 2005
- Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solutionThe Lancet, 2005
- Clinical Characteristics of Dialysis Related Sclerosing Encapsulating Peritonitis: Multi-center Experience in KoreaYonsei Medical Journal, 2005
- Pentoxifylline modulates intracellular signalling of TGF- in cultured human peritoneal mesothelial cells: implications for prevention of encapsulating peritoneal sclerosisNephrology Dialysis Transplantation, 2003
- Bildgebende Diagnostik der sklerosierenden Peritonitis (SP) nach kontinuierlicher ambulanter Peritonealdialyse (CAPD)RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1992